Evidence map›Paper›PMID 27225407›Full record

ArticleJournal of clinical microbiology2016

Multiplex Real-Time PCR Assay with High-Resolution Melting Analysis for Characterization of Antimicrobial Resistance in Neisseria gonorrhoeae.

Valentina Donà, Sara Kasraian, Agnese Lupo, Yuvia N Guilarte, Christoph Hauser, Hansjakob Furrer, Magnus Unemo, Nicola Low, Andrea Endimiani

Registry-linked trialOpen access · bronzeAbstract readValidation Study
In one paragraph

Article in Journal of clinical microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02350907 (Rapid Diagnosis of Antibiotic Resistance in Gonorrhoea), which is not on this map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02350907 completednot on this map

Rapid Diagnosis of Antibiotic Resistance in Gonorrhoea: RaDAR-Go

TypeobservationalSponsorUniversity of BernRan2015 to 2016Enrolled261ConditionsGonorrhoea
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Local emergence and global evolution ofAntimicrobial agents and chemotherapy · 2024
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. A Multiplex Molecular Assay for Detection of SixAntimicrobial agents and chemotherapy · 2022
    Article
  9. Review
  10. Article
  11. Rapid Methods for Antimicrobial Resistance Diagnostics.Antibiotics (Basel, Switzerland) · 2021
    Review
  12. The Laboratory Diagnosis ofPathogens (Basel, Switzerland) · 2020
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Valentina DonàInstitute for Infectious Diseases, University of Bern, Bern, Switzerland.
Sara KasraianInstitute for Infectious Diseases, University of Bern, Bern, Switzerland.
Agnese LupoInstitute for Infectious Diseases, University of Bern, Bern, Switzerland.
Yuvia N GuilarteInstitute for Infectious Diseases, University of Bern, Bern, Switzerland.
Christoph HauserDepartment of Infectious Diseases, Bern University Hospital and University of Bern, Bern, Switzerland.
Hansjakob FurrerDepartment of Infectious Diseases, Bern University Hospital and University of Bern, Bern, Switzerland.
Magnus UnemoÖrebro University, Örebro, Sweden.
Nicola LowInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Andrea EndimianiInstitute for Infectious Diseases, University of Bern, Bern, Switzerland aendimiani@gmail.com.
University of Bern · CHInstitute of Social and Preventive Medicine · CHÖrebro University · SEUniversity Hospital of Bern · CH

Funding

Swiss National Science Foundation 153377
6 · The paper itself

Abstract

Resistance to antibiotics used against Neisseria gonorrhoeae infections is a major public health concern. Antimicrobial resistance (AMR) testing relies on time-consuming culture-based methods. Development of rapid molecular tests for detection of AMR determinants could provide valuable tools for surveillance and epidemiological studies and for informing individual case management. We developed a fast (<1.5-h) SYBR green-based real-time PCR method with high-resolution melting (HRM) analysis. One triplex and three duplex reactions included two sequences for N. gonorrhoeae identification and seven determinants of resistance to extended-spectrum cephalosporins (ESCs), azithromycin, ciprofloxacin, and spectinomycin. The method was validated by testing 39 previously fully characterized N. gonorrhoeae strains, 19 commensal Neisseria species strains, and an additional panel of 193 gonococcal isolates. Results were compared with results of culture-based AMR determination. The assay correctly identified N. gonorrhoeae and the presence or absence of the seven AMR determinants. There was some cross-reactivity with nongonococcal Neisseria species, and the detection limit was 10(3) to 10(4) genomic DNA (gDNA) copies/reaction. Overall, the platform accurately detected resistance to ciprofloxacin (sensitivity and specificity, 100%), ceftriaxone (sensitivity, 100%; specificity, 90%), cefixime (sensitivity, 92%; specificity, 94%), azithromycin (sensitivity and specificity, 100%), and spectinomycin (sensitivity and specificity, 100%). In conclusion, our methodology accurately detects mutations that generate resistance to antibiotics used to treat gonorrhea. Low assay sensitivity prevents direct diagnostic testing of clinical specimens, but this method can be used to screen collections of gonococcal isolates for AMR more quickly than current culture-based AMR testing.

Indexed as

Drug Resistance, BacterialTransition TemperatureGenotyping TechniquesHumansMicrobial Sensitivity TestsMultiplex Polymerase Chain ReactionNeisseria gonorrhoeaeReal-Time Polymerase Chain ReactionSensitivity and Specificity

Identifiers

PMID27225407
PMCPMC4963482
OpenAlexW2397119095

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.